Press Release 2012

Press Release 2012

Dr. Anurag Pande, Vice President, Scientific Affairs, Sabinsa Corporation, will give a presentation on NiLitis®: A Multipronged Approach To Management Of Arthritic Conditions on June 12, 2012 as part of the SupplySide Science Tour held at the Salt Lake City Marriott Downtown, Salt Lake City, Utah.

Dr. Anurag Pande, Vice President, Scientific Affairs, Sabinsa Corporation

NiLitis is a sustained release composition developed by Sabinsa containing phyto-actives which studies have indicated aid inflammation and pain management. It contains three of the most trusted herbal ingredients: Boswellin® (from Boswellia serrata gum), Curcumin C3 Complex® (from turmeric rhizomes) and gingerol from Ginger rhizomes.

A recent clinical trial evaluating the efficacy and safety of NiLitis found measurable end points of reduction in pain and stiffness and better joint function.

Dr. Pande has been with Sabinsa's parent company, Sami Labs, since 2004 in a research capacity, and since 2008 has been based in Sabinsa Japan's Tokyo office as Senior Technical Manager. He holds a PhD in Phytochemistry from RML Awadh University. He has both a Masters degree in Science and a Bachelor's degree in Science from Lucknow University.  

    VISIT US

  • Sabinsa Europe GmbH
    Monzastrasse 4
    63225 Langen
    Germany

  • +49 6103 270 11 11
  • +49 6103 270 11 27
  • info@sabinsa.eu

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.